Validation of GDI, GPS and GVS for use in Parkinson's disease through evaluation of effects of subthalamic deep brain stimulation and levodopa

Carregando...
Imagem de Miniatura
Citações na Scopus
19
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER IRELAND LTD
Autores
SPECIALI, Danielli Souza
CORREA, Joao Carlos Ferrari
GODOY, Wagner de
BAKER, Richard
LUCARELI, Paulo Roberto Garcia
Citação
GAIT & POSTURE, v.39, n.4, p.1142-1145, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The Gait Deviation Index (GDI), Gait Profile Score (GPS) and Gait Variable Scores (GVSs) have been proposed as measures of gait quality and validated for use with children with cerebral palsy. The aim of this study was to extend this validation to people with Parkinson's disease by evaluating the effects of subthalamic deep brain stimulation and levodopa on gait. 16 participants had their gait evaluated with stimulation, medication or a combination of both. The Unified Parkinson's Disease Rating Scale (UPDRS) showed statistically significant differences in agreement with previous studies. The GPS and GDI showed similar treatment effects as did GVS for hip and knee flexion/extension, as assessed with Cohen's d where medium or large. Overall the results suggest that these gait indices are sensitive to treatment in this group of patients and that their use in groups other than children with cerebral palsy is valid.
Palavras-chave
Parkinson's disease, Deep brain stimulation, Gait Profile Score, Gait Deviation Index, Gait
Referências
  1. Allert N, 2001, MOVEMENT DISORD, V16, P1076, DOI 10.1002/mds.1222
  2. Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020
  3. Cohen J, 1988, STAT POWER ANAL BEHA
  4. DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z
  5. Faist M, 2001, BRAIN, V124, P1590, DOI 10.1093/brain/124.8.1590
  6. Ferrarin M, 2002, GAIT POSTURE, V16, P135, DOI 10.1016/S0966-6362(01)00204-1
  7. Ferrarin M, 2005, EXP BRAIN RES, V160, P517, DOI 10.1007/s00221-004-2036-5
  8. FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6
  9. HOEHN MM, 1967, NEUROLOGY, V17, P427
  10. Johnsen EL, 2009, MOVEMENT DISORD, V24, P590, DOI 10.1002/mds.22419
  11. KADABA MP, 1990, J ORTHOPAED RES, V8, P383, DOI 10.1002/jor.1100080310
  12. Krystkowiak P, 2003, ARCH NEUROL-CHICAGO, V60, P80
  13. Lubik S, 2006, J NEURAL TRANSM, V113, P163, DOI 10.1007/s00702-005-0310-8
  14. Morris M, 2005, MOVEMENT DISORD, V20, P40, DOI 10.1002/mds.20278
  15. Rizzone M, 2002, NEUROL SCI, V23, pS103, DOI 10.1007/s100720200090
  16. Schwartz M, 2007, GAIT POSTURE S, V26S, pS11
  17. Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295
  18. Stolze H, 2001, NEUROLOGY, V57, P144
  19. Svehlik M, 2009, ARCH PHYS MED REHAB, V90, P1880, DOI 10.1016/j.apmr.2009.06.017
  20. Xie J, 2001, J NEUROL, V248, P1068, DOI 10.1007/s004150170027